公司資料
Journey Medical Corporation 股價、新聞與催化劑
- 股票代碼:
- DERM
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
6.46 USD (-3.87%)
收盤價
最後更新: 2026年8月17日
166M USD
市值
股價為何變動
As of Aug 17, 2026, DERM closed down 3.87% at $6.46. No new same-company headline was identified in the current news window.
公司概覽
Prescription Dermatology Company
Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.
Emrosi
Emrosi is an oral treatment for inflammatory lesions of rosacea and is central to Journey Medical's current commercial expansion. The product broadens the company's presence in a large chronic dermatology market.
Established Portfolio
Journey Medical markets nine branded prescription drugs for common skin conditions. This portfolio allows the same commercial infrastructure to support multiple products and physician relationships.
Focused Commercial Model
The company emphasizes targeted product acquisition and specialist promotion rather than maintaining a broad internal discovery platform. Journey Medical was founded by Fortress Biotech but operates as a separately listed company.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。